Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICP-B381 in Advanced Solid Tumors
NCT07901413Phase 2Not yet recruiting
- Sponsor
- InnoCare Pharma
- Start
- Nov 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ICP-B381 in solid tumor, prostate cancer (PCa), sponsored by InnoCare Pharma. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ICP-B381
03
Conditions
solid tumorprostate cancer (PCa)
Beyond the preview
Go deeper on NCT07901413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07901413.